Literature DB >> 2820881

Genes for immunodominant protein antigens are highly homologous in Mycobacterium tuberculosis, Mycobacterium africanum, and the vaccine strain Mycobacterium bovis BCG.

M C Lu1, M H Lien, R E Becker, H C Heine, A M Buggs, D Lipovsek, R Gupta, P W Robbins, C M Grosskinsky, S C Hubbard.   

Abstract

The relatedness of immunodominant protein antigens in Mycobacterium tuberculosis, M. africanum, and M. bovis BCG was investigated by comparing the genes that encode major protein antigens in M. tuberculosis with their counterparts in the other two mycobacteria. Genes encoding homologs of M. tuberculosis major protein antigens were isolated from M. africanum and M. bovis BCG by constructing lambda gt11 recombinant DNA expression libraries and screening them with murine monoclonal antibodies and DNA probes. The antibodies were directed against four major protein antigens of M. tuberculosis with molecular masses of 71, 65, 19, and 14 kilodaltons. The isolated M. africanum and M. bovis BCG DNA clones were mapped with restriction endonucleases, and the maps of the mycobacterial genes were confirmed by Southern analysis of mycobacterial genomic DNA. The restriction maps of DNA containing the four genes in M. tuberculosis, M. africanum, and M. bovis BCG are identical, indicating that the immunodominant proteins that they encode are highly homologous in the three mycobacteria. Thus, the immunity against tuberculosis engendered by M. bovis BCG vaccination could be provided, at least in part, by the immune response to these homologous antigens.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2820881      PMCID: PMC260716          DOI: 10.1128/iai.55.10.2378-2382.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Antigenic diversity of Mycobacterium tuberculosis and Mycobacterium bovis detected by means of monoclonal antibodies.

Authors:  A R Coates; J Hewitt; B W Allen; J Ivanyi; D A Mitchison
Journal:  Lancet       Date:  1981-07-25       Impact factor: 79.321

3.  Efficient isolation of genes by using antibody probes.

Authors:  R A Young; R W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

Review 4.  Leprosy and tuberculosis--an epidemiological comparison.

Authors:  P Fine
Journal:  Tubercle       Date:  1984-06

5.  BCG vaccination.

Authors:  F Luelmo
Journal:  Am Rev Respir Dis       Date:  1982-03

6.  Production and partial characterization of monoclonal antibodies to Mycobacterium leprae.

Authors:  T P Gillis; T M Buchanan
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

7.  DNA restriction endonuclease analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG.

Authors:  D M Collins; G W De Lisle
Journal:  J Gen Microbiol       Date:  1984-04

Review 8.  Spectrum of disease due to rapidly growing mycobacteria.

Authors:  R J Wallace; J M Swenson; V A Silcox; R C Good; J A Tschen; M S Stone
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

9.  Yeast RNA polymerase II genes: isolation with antibody probes.

Authors:  R A Young; R W Davis
Journal:  Science       Date:  1983-11-18       Impact factor: 47.728

10.  Selective primary health care: strategies for control of disease in the developing world. V. Leprosy.

Authors:  B R Bloom; T Godal
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug
View more
  9 in total

Review 1.  Immunization against tuberculosis: what kind of vaccine?

Authors:  A J Crowle
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

2.  Isolation and characterization of a recombinant lambda gt11 bacteriophage which expresses an immunoreactive Mycobacterium intracellulare protein in Escherichia coli.

Authors:  S L Morris; D A Rouse; D Hussong; S D Chaparas
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

3.  Expression of Mycobacterium tuberculosis and Mycobacterium leprae proteins by vaccinia virus.

Authors:  J Lyons; C Sinos; A Destree; T Caiazzo; K Havican; S McKenzie; D Panicali; A Mahr
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

4.  Isolation and characterization of recombinant lambda gt11 bacteriophages expressing four different Mycobacterium intracellulare antigens.

Authors:  S L Morris; D A Rouse; D Hussong; S D Chaparas
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

5.  Heterologous expression of the 65-kilodalton antigen of Mycobacterium leprae and murine T-cell responses to the gene product.

Authors:  F I Lamb; A E Kingston; I Estrada; M J Colston
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

6.  Homology of the 70-kilodalton antigens from Mycobacterium leprae and Mycobacterium bovis with the Mycobacterium tuberculosis 71-kilodalton antigen and with the conserved heat shock protein 70 of eucaryotes.

Authors:  R J Garsia; L Hellqvist; R J Booth; A J Radford; W J Britton; L Astbury; R J Trent; A Basten
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

7.  Production, characterization, and species specificity of monoclonal antibodies to Mycobacterium avium complex protein antigens.

Authors:  D A Rouse; S L Morris; A B Karpas; P G Probst; S D Chaparas
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

8.  Comparison of polymerase chain reaction amplification of two mycobacterial DNA sequences, IS6110 and the 65kDa antigen gene, in the diagnosis of tuberculosis.

Authors:  D A Walker; I K Taylor; D M Mitchell; R J Shaw
Journal:  Thorax       Date:  1992-09       Impact factor: 9.139

9.  Effects of Gαi2 and Gαz protein knockdown on alpha2A-adrenergic and cannabinoid CB1 receptor regulation of MEK-ERK and FADD pathways in mouse cerebral cortex.

Authors:  Alfredo Ramos-Miguel; Pilar Sánchez-Blázquez; Jesús A García-Sevilla
Journal:  Pharmacol Rep       Date:  2021-02-28       Impact factor: 3.024

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.